Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 1360-1371 |
Number of pages | 12 |
Journal | The Lancet Oncology |
Volume | 19 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2018 |
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
G. Grignani, L. D'Ambrosio, Y. Pignochino, E. Palmerini, M. Zucchetti, P. Boccone, S. Aliberti, S. Stacchiotti, R. Bertulli, R. Piana, S. Miano, F. Tolomeo, G. Chiabotto, D. Sangiolo, A. Pisacane, A.P. Dei Tos, L. Novara, A. Bartolini, E. Marchesi, M. D'Incalci
Research output: Contribution to journal › Article › peer-review